Cargando…

Differential tissue expression of extracellular vesicle‐derived proteins in prostate cancer

BACKGROUND: Proteomic profiling of extracellular vesicles (EVs) from prostate cancer (PCa) and normal prostate cell lines, led to the identification of new candidate PCa markers. These proteins included the nuclear exportin proteins XPO1 (also known as CRM1), the EV‐associated PDCD6IP (also known as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duijvesz, Diederick, Rodriguez‐Blanco, Giovanny, Hoogland, A. Marije, Verhoef, Esther I., Dekker, Lennard J., Roobol, Monique J., van Leenders, Geert J. L. H., Luider, Theo M., Jenster, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594141/ https://www.ncbi.nlm.nih.gov/pubmed/31018022 http://dx.doi.org/10.1002/pros.23813

Ejemplares similares

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
por: Rodríguez-Blanco, Giovanny, et al.
Publicado: (2018)

Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer
por: Duijvesz, Diederick, et al.
Publicado: (2013)

Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer
por: Hoogland, A. Marije, et al.
Publicado: (2016)

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer
por: Böttcher, René, et al.
Publicado: (2015)

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis
por: Hollemans, Eva, et al.
Publicado: (2018)

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy
por: Hollemans, Eva, et al.
Publicado: (2020)

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens
por: Hollemans, Eva, et al.
Publicado: (2019)

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
por: Hoogland, A. Marije, et al.
Publicado: (2014)

MET expression during prostate cancer progression
por: Verhoef, Esther I., et al.
Publicado: (2016)

Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases
por: Böttcher, René, et al.
Publicado: (2016)

Effects of the IDH1 R132H Mutation on the Energy Metabolism: A Comparison between Tissue and Corresponding Primary Glioma Cell Cultures
por: Dekker, Lennard J. M., et al.
Publicado: (2022)

Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer
por: Kolijn, Kimberley, et al.
Publicado: (2015)

Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading
por: van Leenders, Geert J L H, et al.
Publicado: (2020)

Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients
por: Hollemans, Eva, et al.
Publicado: (2020)

Extracellular Vesicle Quantification and Characterization: Common Methods and Emerging Approaches
por: Hartjes, Thomas A., et al.
Publicado: (2019)

Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies
por: Rijstenberg, L Lucia, et al.
Publicado: (2022)

Genome-Wide Investigation of Multifocal and Unifocal Prostate Cancer—Are They Genetically Different?
por: Ibeawuchi, Chinyere, et al.
Publicado: (2013)

Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer
por: Martens‐Uzunova, Elena S., et al.
Publicado: (2021)

mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma
por: Stelloo, Suzan, et al.
Publicado: (2016)

Screening for prostate cancer: are organized screening programs necessary?
por: Roobol, Monique J.
Publicado: (2018)

Prostate cancer screening and active surveillance in the Western world
por: Roobol, Monique J.
Publicado: (2018)

Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy
por: Ibeawuchi, Chinyere, et al.
Publicado: (2015)

Dimerization of Peptides by Calcium Ions: Investigation of a Calcium-Binding Motif
por: Jamalian, Azadeh, et al.
Publicado: (2014)

Activation of c-MET Induces a Stem-Like Phenotype in Human Prostate Cancer
por: van Leenders, Geert J. L. H., et al.
Publicado: (2011)

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
por: Osses, Daniël F., et al.
Publicado: (2020)

Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future?
por: Roobol, Monique J.
Publicado: (2021)

Collagen Peptides in Urine: A New Promising Biomarker for the Detection of Colorectal Liver Metastases
por: Bröker, Mirelle E. E., et al.
Publicado: (2013)

Androgen receptor profiling predicts prostate cancer outcome
por: Stelloo, Suzan, et al.
Publicado: (2015)

Personalized strategies in population screening for prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2020)

Label-free peptide profiling of Orbitrap™ full mass spectra
por: Titulaer, Mark K, et al.
Publicado: (2011)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Immune Repertoire after Immunization As Seen by Next-Generation Sequencing and Proteomics
por: VanDuijn, Martijn M., et al.
Publicado: (2017)

Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles
por: Stevic, Ines, et al.
Publicado: (2020)

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling
por: Van Hemelryk, Annelies, et al.
Publicado: (2022)

Ethnicity and prostate cancer: the way to solve the screening problem?
por: Bokhorst, Leonard P., et al.
Publicado: (2015)

Extracellular Vesicles: From Biology to Biomedical Applications
por: Serrano-Pertierra, Esther, et al.
Publicado: (2019)

An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions
por: Dekker, Lennard J. M., et al.
Publicado: (2010)

Expression of virulence and antimicrobial related proteins in Burkholderia mallei and Burkholderia pseudomallei
por: Paauw, Armand, et al.
Publicado: (2023)

From PROMIS to PRO-MRI in primary prostate cancer diagnosis
por: Schoots, Ivo G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7fo4ckbuki9r7d3klf83oq26l5